NCT05173129

Brief Summary

Hemophilia A and B are inherited disorders characterized by deficient or missing coagulation factors VIII or IX, respectively, of which the main long-term clinical manifestation is joint damage. Patients with haemophilia (PwH) are susceptible to clinical joint bleeding that may cause irreversible joint damage. Some degree of damage may already occur after the first haemarthrosis or even in children who never experienced clinically evident joint bleeds. Joints are mechanical systems with a structure strictly related to functioning. Therefore, any alteration in structure may have an impact on function (starting from the primary level of posture and anti-gravity muscles), which might in turn stress the joints and increase the risk of bleeding.The primary aim of this study is to investigate the changes in posture and the mechanical properties of anti-gravity muscles of adolescent PwH. The secondary aim is to determine the effect of joint dysfunction on posture in adolescent PwH.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 20, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 29, 2021

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2022

Completed
Last Updated

August 5, 2022

Status Verified

August 1, 2022

Enrollment Period

5 months

First QC Date

November 20, 2021

Last Update Submit

August 3, 2022

Conditions

Keywords

haemophiliapostureanti-gravity musclesjoint health

Outcome Measures

Primary Outcomes (2)

  • Photogrammetry

    The photogrammetry is a single evaluation method based on the analysis of two-dimensional photographs with a software.The erect-static posture of the participants will be analyzed with photogrammetry method. Firstly, two-dimensional photographs of the participant in the static-erect position will be taken.Afterwards, spinal and extremity angles will be measured in degrees using Kinovea™ software in the two-dimensional photographs transferred to the computer.

    Baseline

  • Myotonometric assessment

    Myotonometric assessment is a reliable method in which the stiffness, elasticity and tone of the muscles are evaluated with a single measurement method.The mechanical properties (tone, stiffness, and elasticity) of the superficial muscles that affect posture will be evaluated with Myoton Pro™ device (Myoton AS, Tallinn, Estonia). With a single measurement made with Myoton Pro™ device, numerical values reflecting the mechanical properties of the muscle are obtained on the screen of the device.

    Baseline

Secondary Outcomes (1)

  • Haemophilia Joint Health Score

    Baseline

Study Arms (2)

Haemophilic boys

EXPERIMENTAL

Adolescent boys with haemophilia

Diagnostic Test: Posture Analysis

Healthy boys

ACTIVE COMPARATOR

Healthy adolescent boys

Diagnostic Test: Posture Analysis

Interventions

Posture AnalysisDIAGNOSTIC_TEST

Posture analysis and assessment of mechanical properties of posture muscles

Haemophilic boysHealthy boys

Eligibility Criteria

Age10 Years - 19 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Adolescent boys with haemophilia A or haemophilia B (for experimental group) and healthy adolescent boys (for control group).

You may not qualify if:

  • To be with another congenital coagulopathy such as von Willebrand syndrome.
  • To be unable to stand without support due to hemophilic arthropathy.
  • To be having another musculoskeletal problem.
  • To be having factor VIII or IX level in the plasma above 6%

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cukurova University

Adana, 01100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hemophilia AMuscular Diseases

Condition Hierarchy (Ancestors)

Blood Coagulation Disorders, InheritedBlood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesCoagulation Protein DisordersHemorrhagic DisordersGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Nevin A Guzel, Prof. Dr.

    Gazi University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: cross-sectional study for two groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

November 20, 2021

First Posted

December 29, 2021

Study Start

September 1, 2021

Primary Completion

January 15, 2022

Study Completion

February 15, 2022

Last Updated

August 5, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations